D4G Stock Overview Engages in the collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence in Canada and South Korea. More details
Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Add noteDatametrex AI Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Datametrex AI Historical stock prices Current Share Price CA$0.0038 52 Week High CA$0.04 52 Week Low CA$0.0002 Beta 2.33 1 Month Change 280.00% 3 Month Change 1,800.00% 1 Year Change 58.33% 3 Year Change -96.98% 5 Year Change -52.50% Change since IPO -94.57%
Recent News & Updates
Datametrex AI Limited, Annual General Meeting, Nov 13, 2024 Sep 24 Datametrex AI Limited Announces Chief Executive Officer Changes
Datametrex AI Limited Implements AI Technology at Imagine Health Centres To Streamline Patient Care and Enhance Healthcare Accessibility Sep 10
Datametrex AI Limited Announces Official Launch of Cereal Crunch on Google Play Store Sep 05
First quarter 2025 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in 1Q 2024) Sep 01
New major risk - Shareholder dilution Aug 23 See more updates
Datametrex AI Limited, Annual General Meeting, Nov 13, 2024 Sep 24 Datametrex AI Limited Announces Chief Executive Officer Changes
Datametrex AI Limited Implements AI Technology at Imagine Health Centres To Streamline Patient Care and Enhance Healthcare Accessibility Sep 10
Datametrex AI Limited Announces Official Launch of Cereal Crunch on Google Play Store Sep 05
First quarter 2025 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in 1Q 2024) Sep 01
New major risk - Shareholder dilution Aug 23 Datametrex AI Limited announced that it has received CAD 1.521909 million in funding Aug 21
Full year 2024 earnings released: CA$0.047 loss per share (vs CA$0.05 loss in FY 2023) Jul 31 Datametrex AI Limited announced that it expects to receive CAD 1.5 million in funding Jun 14
Full year 2023 earnings released: CA$0.034 loss per share (vs CA$0.045 loss in FY 2022) Mar 03
New minor risk - Shareholder dilution Feb 28 Datametrex AI Limited announced that it has received CAD 1 million in funding Feb 27
Datametrex AI Limited announced that it expects to receive CAD 1 million in funding Feb 02
Datametrex Ai Limited Announces CEO Changes
Graph Blockchain Inc. (CNSX:GBLC) completed the acquisition of Datametrex Electric Vehicle Solutions from Datametrex AI Limited (TSXV:DM). Dec 08
Third quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.002 profit in 3Q 2022) Dec 01
New major risk - Market cap size Nov 15
Graph Blockchain Inc. (CNSX:GBLC) entered into an agreement to acquire Datametrex Electric Vehicle Solutions from Datametrex AI Limited (TSXV:DM) for approximately CAD 3.2 million. Nov 15
Insufficient new directors Nov 02
CEO & Director recently sold €68k worth of stock Oct 09
Datametrex AI Limited, Annual General Meeting, Dec 14, 2023 Oct 05
Datametrex AI Limited Appoints Young Jun Kim as New Head of Defense Business Development for the Company's Business Division in South Korea Sep 28
Nexalogy Environics Inc. Launches AnalyticsGPT Sep 20
Second quarter 2023 earnings released: CA$0.008 loss per share (vs CA$0.002 loss in 2Q 2022) Sep 03
Datametrex Electric Vehicle Solutions Inc. Expands Operations to Toronto Jul 26
First quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.007 profit in 1Q 2022) Jun 02
Datametrex AI Limited Announces the Appointment of Charles Park as Chief Operating Officer May 05
Full year 2022 earnings released: CA$0.045 loss per share (vs CA$0.028 profit in FY 2021) May 03
Datametrex AI Limited (TSXV:DM) acquired Imagine Health Centers for $2.6 million. Dec 01
Second quarter 2022 earnings released: CA$0.002 loss per share (vs CA$0.003 profit in 2Q 2021) Nov 22
High number of new and inexperienced directors Nov 16
Datametrex AI Limited Appoints Mr. Charles Park as the President of Nexalogy Nov 03
CEO & Director recently bought €74k worth of stock Oct 22
Datametrex AI Limited Launches Smart Factory Platform Sep 17
Second quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.003 profit in 2Q 2021) Aug 27
Datametrex Ai Limited Announces Company's Wholly Owned Telehealth Subsidiary, Medi-Call Inc., Introduces Mental Health Services Jul 27
Datametrex AI Limited Announces Telehealth Medi-Call App Is Now Available Jun 29
CEO & Director recently bought €74k worth of stock Jun 17
Less than half of directors are independent May 28
Datametrex AI Limited, Annual General Meeting, Jul 29, 2022 May 21 Datametrex AI Limited Announces Promotion Of Maxime Martineau as New Chief Technology Officer May 10
Executive Chairman recently bought €107k worth of stock May 06
Full year 2021 earnings released: EPS: CA$0.028 (vs CA$0.02 loss in FY 2020) May 04
Datametrex AI Limited to Report Fiscal Year 2021 Results on May 02, 2022 May 02
High number of new and inexperienced directors Apr 27
Datametrex AI Limited Launches Tele-Medicine Services Via Medi-Call App Apr 20
Datametrex Launches Beta Testing of Medi- Call Telehealth App Mar 03
Executive Chairman recently bought €84k worth of stock Jan 12
Third quarter 2021 earnings: Revenues miss analyst expectations Nov 30
Second quarter 2021 earnings released: EPS CA$0.003 (vs CA$0.003 loss in 2Q 2020) Aug 18
Datametrex AI Limited (TSXV:DM) completed the acquisition of Medi-Call Inc. Jun 22
First quarter 2021 earnings released: EPS CA$0.034 (vs CA$0.003 loss in 1Q 2020) Jun 05
Full year 2020 earnings released: CA$0.02 loss per share (vs CA$0.012 loss in FY 2019) May 03
Independent Director has left the company Mar 25
Executive Chairman recently sold €1.1m worth of stock Mar 24
Datametrex AI Limited (TSXV:DM) entered into a Letter of Intent to acquire Perspectum Drone Inspection Services Ltd. Mar 12
New 90-day high: €0.22 Mar 02
New 90-day high: €0.21 Feb 23
Jibran Sharif to Become the Chief Medical Officer of Datametrex AI Limited Feb 13
Datametrex AI Limited (TSXV:DM) completed the acquisition of Concierge Medical Consultant Inc. Feb 12
Executive Chairman recently sold €282k worth of stock Feb 12
Datametrex AI Limited Secures Exclusive Rights to Sell and Distribute Covid-19 Saliva Kit Manufactured by WIZCHEM CO., LTD Feb 04
Datametrex AI Limited Expands LOTTE Agreements Jan 22
Executive Chairman recently sold €995k worth of stock Jan 20
Datametrex Provides Covid-19 Testing for Air Canada Front-Line and Inflight Employees Jan 12
Datametrex AI Limited (TSXV:DM) entered into letter of intent to acquire Concierge Medical Consultant Inc. for CAD 0.75 million. Jan 09
Datametrex AI COVID Test Kit Detects the New Strain Jan 06
Datametrex AI Limited AI Ramps up COVID-19 Testing for Film & Television Sectors Dec 19
Datametrex AI Announces Release of Nexalogy SMART Technology Dec 18
Datametrex AI Limited Wins Contracts with Insurance Provider and Airport Authority Dec 17
Datametrex AI Limited Provides Update on the 1copyTM COVID-19 Test Kit Dec 03
Third quarter 2020 earnings released: CA$0.002 loss per share Nov 26
Datametrex Deploys New AI Non-Contact Temperature Assessment Device Oct 16 Datametrex AI Limited Announces the Development of an Advanced Statistical Model to Assess the Current State of the Pandemic and to Monitor COVID-19 Hotspots Using Artificial Intelligence and Machine Learning Shareholder Returns D4G DE IT DE Market 7D 0% 3.0% 1.9% 1Y 58.3% -19.6% 15.1%
See full shareholder returns
Return vs Industry: D4G exceeded the German IT industry which returned -19.6% over the past year.
Return vs Market: D4G exceeded the German Market which returned 15.1% over the past year.
Price Volatility Is D4G's price volatile compared to industry and market? D4G volatility D4G Average Weekly Movement 629.8% IT Industry Average Movement 5.1% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.3% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: D4G's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: D4G's weekly volatility has decreased from 805% to 630% over the past year, but is still higher than 75% of German stocks.
About the Company Datametrex AI Limited engages in the collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence in Canada and South Korea. The company operates through two segments, AI and Technology and Health Care. It offers health security businesses, including concierge medical services, and telemedicine services; Imagine Health consisting of integrated medical centre, pharmacy, and ancillary services; physician consultation and medical professional services; and sale of prescription drugs and over-the-counter products.
Show more Datametrex AI Limited Fundamentals Summary How do Datametrex AI's earnings and revenue compare to its market cap? D4G fundamental statistics Market cap €4.11m Earnings (TTM ) -€10.18m Revenue (TTM ) €5.97m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) D4G income statement (TTM ) Revenue CA$9.00m Cost of Revenue CA$5.30m Gross Profit CA$3.70m Other Expenses CA$19.04m Earnings -CA$15.34m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.025 Gross Margin 41.08% Net Profit Margin -170.44% Debt/Equity Ratio 23.7%
How did D4G perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/02 11:21 End of Day Share Price 2025/01/31 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Datametrex AI Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Siddharth Rajeev Fundamental Research Corp.
Show 0 more analysts